Nasus Pharma Ltd
Develops powder-based intranasal therapies for acute medical emergencies.
NSRX | US
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 29 HARAKEVET ST, 6618003 TEL AVIV - YAFO
- Website:
- https://www.nasuspharma.com
- Sector:
- Manufacturing
Description
Nasus Pharma Ltd. is a clinical-stage pharmaceutical company that develops powder-based intranasal (PBI) therapies for acute and life-threatening medical emergencies. The company utilizes its proprietary Nasax® technology platform, which is engineered for the rapid and precise delivery of drugs to the bloodstream. This powder formulation technology aims to provide faster onset of action, higher bioavailability, and improved stability compared to traditional injectable or liquid formulations. Its lead product candidate, NS002, is an intranasal epinephrine powder developed for the emergency treatment of severe allergic reactions (anaphylaxis).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
|
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB
Full Filing History RestrictedAccess to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset. |
|||||
Automate Your Workflow. Get a real-time feed of all Nasus Pharma Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Nasus Pharma Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Nasus Pharma Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
